These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25523559)

  • 1. Malignancies in inflammatory bowel disease.
    Nieminen U; Färkkilä M
    Scand J Gastroenterol; 2015 Jan; 50(1):81-9. PubMed ID: 25523559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease.
    Chang M; Chang L; Chang HM; Chang F
    Clin Colorectal Cancer; 2018 Mar; 17(1):e29-e37. PubMed ID: 28712945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cancer in IBD - a balancing act.
    Mill J; Lawrance IC
    Minerva Gastroenterol Dietol; 2013 Sep; 59(3):261-72. PubMed ID: 23867946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
    Beaugerie L; Sokol H; Seksik P
    Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IBD-related carcinoma and lymphoma.
    Claessen MM; Siersema PD; Vleggaar FP
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
    Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
    J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience.
    Madanchi M; Zeitz J; Barthel C; Samaras P; Scharl S; Sulz MC; Biedermann L; Frei P; Vavricka SR; Rogler G; Scharl M
    Digestion; 2016; 94(1):1-8. PubMed ID: 27318857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who and how to screen for cancer in at-risk inflammatory bowel disease patients.
    Parian A; Lazarev M
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):731-46. PubMed ID: 25592672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis.
    Jess T; Lopez A; Andersson M; Beaugerie L; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1793-1800.e1. PubMed ID: 24907505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
    Herszényi L; Barabás L; Miheller P; Tulassay Z
    Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
    Beigel F; Steinborn A; Schnitzler F; Tillack C; Breiteneicher S; John JM; Van Steen K; Laubender RP; Göke B; Seiderer J; Brand S; Ochsenkühn T
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K; Tulassay Z
    Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease associated neoplasia: A surgeon's perspective.
    Althumairi AA; Lazarev MG; Gearhart SL
    World J Gastroenterol; 2016 Jan; 22(3):961-73. PubMed ID: 26811640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: The relevance of surveillance endoscopy in long-lasting inflammatory bowel disease.
    Vleggaar FP; Lutgens MW; Claessen MM
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():47-52. PubMed ID: 18081648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplasia and cancer in inflammatory bowel disease.
    Basseri RJ; Basseri B; Papadakis KA
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
    Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
    Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.